Key opportunities in the AI clinical genomics interpretation market include the rising demand for precision medicine, wider adoption of AI-powered tools, advancements in predictive analytics, ...

Thermo Fisher Scientific is breaking out the big bills to score a clinical research treat. With $8.875 billion in cash, the ...

This one-day symposium on Friday, Nov. 14, will convene leaders in neuroscience, clinical research, biomedical engineering, and data science to explore strategies for advancing open and equitable scie ...

As the world becomes more digital, clinical research is evolving. One major change is the rise of decentralized clinical ...

Life sciences giant Thermo Fisher Scientific has agreed to acquire clinical trials software company Clario for a consideration of up to $9.4bn.

AI has the potential to transform life sciences commercialization, but only if we design it around people. Machines bring ...

The Impossible Dream Machine, an initiative founded by Broadway actor, Grammy-nominated singer, and ALS patient and advocate ...

Because researchers have made such striking progress in developing drugs to treat neuromuscular diseases, Scott Delp, Ph.D., ...

Thermo Fisher said on Wednesday it would buy privately held data management company Clario for up to $9.4 billion in cash and ...

Global Pharmacovigilance Market OverviewThe Global Pharmacovigilance (PV) Market is projected to expand at a healthy growth rate of 8–9% over the next five years. The market’s momentum is fueled by ...

Dose-dependent mean reductions of Activin E of up to 85% one month post single dose of WVE-007 in INLIGHT clinical trial, exceeding levels that led to weight loss in preclinical models; WVE-007 is gen ...